Skip to main content

CORRECTION article

Front. Endocrinol., 22 February 2023
Sec. Thyroid Endocrinology

Corrigendum: Effect of 131 I with and without artificial liver support system in patients with Graves’ disease and severe liver dysfunction: A retrospective study

Maohua Rao&#x;Maohua Rao1†Yirui Wang&#x;Yirui Wang1†Jianli RenJianli Ren2Yue ChenYue Chen3Chenxi ZhengChenxi Zheng1Yalan XiongYalan Xiong1Qingbo YanQingbo Yan1Shiying Li*Shiying Li4*Gengbiao Yuan*Gengbiao Yuan1*
  • 1Department of Nuclear Medicine, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China
  • 2Chongqing Key Laboratory of Ultrasound Molecular Imaging, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China
  • 3Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province, Luzhou, China
  • 4Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China

A Corrigendum on
Effect of 131I with and without artificial liver support system in patients with Graves’ disease and severe liver dysfunction: A retrospective study

By Rao M, Wang Y, Ren J, Chen Y, Zheng C, Xiong Y, Yan Q, Li S and Yuan G (2022) Front. Endocrinol. 13:1034374. doi: 10.3389/fendo.2022.1034374

In the published article, there was an error in the author list. The symbol indicating which authors shared co-first authorship was erroneously missed. The corrected author list appears below, using the symbol to define which authors share first authorship.

Maohua Rao1†, Yirui Wang1†, Jianli Ren2, Yue Chen3, Chenxi Zheng1, Yalan Xiong1, Qingbo Yan1, Shiying Li4*and Gengbiao Yuan1*

The authors apologize for this error and state that this does not change the scientific conclusions of the article in anyway. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: thyroid, severe liver dysfunction, artificial liver support system, radioiodine, therapeutics

Citation: Rao M, Wang Y, Ren J, Chen Y, Zheng C, Xiong Y, Yan Q, Li S and Yuan G (2023) Corrigendum: Effect of 131 I with and without artificial liver support system in patients with Graves’ disease and severe liver dysfunction: A retrospective study. Front. Endocrinol. 14:1136544. doi: 10.3389/fendo.2023.1136544

Received: 03 January 2023; Accepted: 10 February 2023;
Published: 22 February 2023.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2023 Rao, Wang, Ren, Chen, Zheng, Xiong, Yan, Li and Yuan. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Shiying Li, 302946@hospital.cqmu.edu.cn; Gengbiao Yuan, 300784@hospital.cqmu.edu.cn

These authors have contributed equally to this work and share first authorship

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.